US-based health technology company Masimo and Cleveland Clinic, a non-profit academic medical centre, have partnered to improve hospital-based remote patient monitoring (RPM).
Under the collaboration, Cleveland Clinic will integrate its critical care (eHospital) and non-critical care (eCMU) patient monitoring platforms with Masimo’s Hospital Automation platform.
Through the partnership, the two organisations aim to provide clinicians with tools that enhance situational awareness and clinical decision support for hospitalised patients.
The collaboration will include joint development initiatives on predictive analytics and AI-based algorithms for improving cardiac care.
Masimo founder and CEO Joe Kiani said: “We are truly honoured to have the opportunity to partner with Cleveland Clinic to advance patient care.
“Our partnership has the potential to significantly ease staff shortages, better standardise care, and promote intensivist- and specialist-led care.
Ultimately, we will make significant strides in shifting from reactive to predictive and proactive care – improving patient outcomes, safety, and quality of care across the board.”
Cleveland Clinic’s eHospital and eCMU platforms continuously monitor a wide range of vital signs for ICU and non-ICU patients at over 2,000-bed capacity.
The clinic’s hospital-based RPM programs serve 11 hospitals, providing intensivist monitoring, 24/7 critical care nursing, and patient management.
The Masimo Hospital Automation platform is designed to provide technologies that help clinicians improve patient care at the bedside, across the care continuum.
It includes monitoring and wearable technologies, high-fidelity medical device integration, and system-wide applications for surveillance and data visualisation.
The platform also includes novel AI capabilities that support intelligent patient prioritisation and help clinicians more effectively identify changes in their patient’s condition.
Cleveland Clinic ICU operations medical director Chiedozie Udeh said: “We see great opportunities to enhance remote care, particularly for critically ill individuals.
“By combining our technical and clinical expertise, we aim to improve situational awareness for clinicians and continue to improve outcomes for patients.”
The decision-support tools are integrated into the Masimo Hospital Automation platform and utilise the Halo engine, a technology that identifies deterioration patterns in real-time.
The Halo tools include Halo ION, a scalable, and customisable continuous early warning score to help streamline patient assessment and clinical workflows.
Masimo and Cleveland Clinic will jointly develop an additional Halo-based decision-support tool to support clinicians with earlier detection of adverse events.
Cleveland Clinic heart, vascular and thoracic institute staff cardiologist and AI study principal investigator Thomas Callahan said: “We look forward to exploring the effects of next-gen inpatient wearables, and as the capabilities of AI continue to advance, studying the potential impact on the care of cardiac patients, including those undergoing cardiac surgery.”
